Tag: Gefapixant
Salud
Merck Provides U.S. and Japan Regulatory Update for Gefapixant
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S....
Want to stay up to date with the latest news?
We would love to hear from you! Please fill in your details and we will stay in touch. It's that simple!